Is L-carnitine safe during pregnancy?

What does the evidence say about L-carnitine during pregnancy?

1. Small case reports describe pregnant women with narcolepsy taking oral L-carnitine (510 mg to 1,000 mg daily) in place of their usual medications. The authors called the approach safe, and one case noted delivery and breastfeeding without complications. 1
2. In two case reports of pregnant women with confirmed primary carnitine deficiency, carnitine supplementation (1,500 mg to 8 grams daily depending on the case) was adjusted throughout pregnancy based on blood plasma levels, and both pregnancies had uneventful outcomes. 2
3. StatPearls describes carnitine's core job as shuttling long-chain fatty acids into mitochondria for energy production. It calls pregnancy metabolically demanding enough for someone with primary carnitine deficiency that specialist planning is recommended beforehand, and lists the general high-dose oral regimen for confirmed deficiency as 100 to 200 mg per kilogram daily in three divided doses, noting oral bioavailability is only 5 to 18 percent. 3
4. LactMed states that no data exist on the safety and efficacy of levocarnitine supplementation in nursing mothers or infants without carnitine deficiency, and advises avoiding supplementation during breastfeeding unless a healthcare professional prescribes it. When adults do use it, the most common effects are mild gastrointestinal upset and restlessness, plus a fishy odor to breath, sweat, or urine. 4
5. A 2023 nutrition review states that most adults meet their carnitine needs, roughly 20 to 200 mg per day, through diet plus the body's own production from methionine and lysine, that fish, meat, and dairy give better-absorbed carnitine than supplements do, and that up to 2,000 mg per day has been set as a safe upper level for chronic supplement use in the general population. 5

Is L-carnitine safe in each trimester?

• First trimester. No trials look specifically at first-trimester L-carnitine use. The available human evidence is case reports in women who had narcolepsy or confirmed carnitine deficiency before pregnancy, not routine first-trimester supplementation in an otherwise healthy pregnancy.
• Second trimester. There is no dedicated second-trimester dosing evidence either. The case reports describe carnitine doses being adjusted against blood plasma levels throughout pregnancy rather than following one fixed schedule, which is a different approach than a standard label dose.
• Third trimester. Third-trimester data is limited to the same small case reports, which describe continued plasma monitoring rather than a set maintenance dose, so any late-pregnancy use still calls for provider oversight and lab follow-up.